This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Korea Research Institute of Chemical Technology, National Cancer Center. Active years: 2018-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2018-2022
Title: Kyung Chae Jeong: Innovator in Anticancer Research
Introduction
Kyung Chae Jeong is a prominent inventor based in Goyang-si, South Korea. He has made significant contributions to the field of cancer research, particularly in the development of pharmaceutical compositions aimed at treating and preventing cancer. With a total of 3 patents to his name, Jeong's work is paving the way for innovative cancer therapies.
Latest Patents
One of Jeong's latest patents is an anticancer pharmaceutical composition that provides a method for treating or preventing cancer. This composition contains, as an active ingredient, a compound with a specific chemical structure that inhibits the formation of a c-Myc/Max/DNA complex. Additionally, he has developed compounds specifically designed to inhibit c-Myc/Max/DNA complex formation, which are novel compounds with unique chemical structures and inhibitory activity.
Career Highlights
Throughout his career, Kyung Chae Jeong has worked with esteemed institutions such as the Korea Research Institute of Chemical Technology and the National Cancer Center. His research has focused on innovative approaches to combat cancer, contributing to the advancement of medical science.
Collaborations
Jeong has collaborated with notable colleagues in his field, including Hwan Jung Lim and Seong Jun Park. These partnerships have enhanced his research efforts and expanded the impact of his work in cancer treatment.
Conclusion
Kyung Chae Jeong's contributions to cancer research through his innovative patents and collaborations highlight his dedication to improving therapeutic options for patients. His work continues to inspire advancements in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile